Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Oral Single Dose of TAK-418 in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety, tolerability, and pharmacokinetics of ascending single oral dose TAK-418 in healthy participants completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Participants

Drugs mentioned

• TAK-418

Snippet

Sponsor: Takeda | Conditions: Healthy Participants | Phase 1 | Status: COMPLETED | Results posted: 2019-09-09